0
0

Formula 3.0 Act

3/11/2024, 5:36 PM

Summary of Bill S 1782

Bill 118 s 1782, also known as the Formula 3.0 Act, is a piece of legislation currently being considered by the US Congress. The main purpose of this bill is to update and improve the formula used to allocate federal funding to states for various programs and initiatives.

The Formula 3.0 Act aims to create a more equitable and efficient distribution of federal funds by taking into account factors such as population size, poverty rates, and infrastructure needs. This updated formula is designed to better reflect the current needs and priorities of each state, ensuring that resources are allocated in a way that maximizes their impact and effectiveness.

In addition to updating the funding formula, the bill also includes provisions for increased transparency and accountability in the allocation process. This includes requirements for states to report on how federal funds are being used and the outcomes achieved, as well as mechanisms for monitoring and evaluating the effectiveness of the funding distribution. Overall, the Formula 3.0 Act represents a significant step towards improving the way federal funds are allocated to states, with the goal of ensuring that resources are distributed in a fair and effective manner. This legislation has the potential to have a positive impact on a wide range of programs and initiatives, from education and healthcare to infrastructure and economic development.

Congressional Summary of S 1782

Formula 3.0 Act

This bill provides duty-free treatment to certain infant formula and infant formula base powder.

The bill defines infant formula base powder as a dry mixture of protein, fat, and carbohydrates that requires only the addition of vitamins and minerals in order to meet the definition of the term infant formula in the Federal Food, Drug, and Cosmetic Act. It must be (1) imported by a party that has been determined by the Food and Drug Administration (FDA) to be authorized to lawfully market infant formula in the United States or has received a letter of enforcement discretion from the FDA relating to the marketing of its infant formula in the United States, and (2) intended to be used in manufacturing infant formula in the United States.

The bill also removes the limitation on the aggregate quantity of certain infant formula containing oligosaccharides (carbohydrates) that may enter the United States in any calendar year.

Current Status of Bill S 1782

Bill S 1782 is currently in the status of Bill Introduced since May 31, 2023. Bill S 1782 was introduced during Congress 118 and was introduced to the Senate on May 31, 2023.  Bill S 1782's most recent activity was Read twice and referred to the Committee on Finance. as of May 31, 2023

Bipartisan Support of Bill S 1782

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
10
Democrat Cosponsors
2
Republican Cosponsors
8
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 1782

Primary Policy Focus

Foreign Trade and International Finance

Alternate Title(s) of Bill S 1782

Formula 3.0 Act
Formula 3.0 Act
A bill to provide for the entry of infant formula and infant formula base powder free of duty and free of quantitative limitation.
A bill to provide for the entry of infant formula and infant formula base powder free of duty and free of quantitative limitation.

Comments